Regulation - Research, Aubagio

Filter

Current filters:

ResearchAubagio

Popular Filters

Sanofi pays $3 million milestone to ImmunoGen on start of SAR3419 Ph II testing; FDA accepts Aubagio filing

21-10-2011

US biotech firm ImmunoGen (Nasdaq: IMGN) says that SAR3419 has started Phase II testing, which triggers…

AubagioBiotechnologyFinancialGenzymeImmunoGenNeurologicalOncologyPharmaceuticalRegulationResearchSanofi

Company Spotlight

ImmunoGen

ImmunoGen

Back to top